Purchase of lab equipment to aid IIT Madras, DMST, high speed ultracentrifuge
Principal Investigator
Prof. DMST
Objective
- To establish a state-of-the-art Cancer Nanomedicine Laboratory capable of producing highly purified polymer nanoparticles and nanogels for overcoming drug resistance and cancer metastasis.
Description
- India faces a steep rise in cancer incidence, crossing 1.46 million new cases per year. Conventional chemotherapy often fails because of: poor drug delivery to tumours, high systemic toxicity, drug resistance, etc. These limitations highlight the urgent need for nanomedicine. Nanomedicine enables precise tumour targeting, deep tissue penetration and sustained drug release. However, the single most important step in manufacturing high-quality, clinically translatable nanoparticles is ultracentrifugation. At present, IIT Madras does not have an ultracentrifuge in the Department of Medical Sciences & Technology (DMST). This is a critical infrastructural gap that directly limits cancer nanomedicine research and the development of next-generation therapeutics for India's growing cancer burden.
Impact
- Enhanced Research Output., High-Impact Publications and Patents., Development of Targeted Nanotherapeutics for Indian Cancer Patients., Capacity Building for National Research Ecosystem., Societal Impact Through Improved Therapeutic Solutions.
Budget in Lakhs
99.86
Duration
3 Months